PATIENT TEMPERATURE MONITORING MARKET ANALYSIS

Patient Temperature Monitoring Market, by Product (Smart Temperature Monitoring Patches, Wearable Continuous Monitoring Sensors, Handheld Temperature Monitoring Devices (Mercury Thermometers, Digital Thermometer, and Infrared Thermometer), and Invasive Temperature Monitoring Devices), by Site (Noninvasive Temperature Monitoring (Tympanic Membrane Temperature Monitoring, Oral Temperature Monitoring, and Axillary and Temporal Artery Temperature Monitoring) and Invasive Temperature Monitoring (Rectal Temperature Monitoring, Esophageal Temperature Monitoring, Nasopharynx Temperature Monitoring, Urinary Bladder Temperature Monitoring)), by Application (Blood Transfusion, Hypothermia, Anesthesia, Pyrexia/Fever, and Others), by End User (Hospitals (Emergency Rooms, Intensive Care Units, and Operating Rooms), Ambulatory Care Centers, Nursing Facilities, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Oct 2022
Code : CMI5291
Pages :274
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

Global Patient Temperature Monitoring Market: Restraint

The major factor that is expected to hinder growth of the global patient temperature monitoring market include increasing product recall. Increasing product recalls by regulatory authorities is expected to hamper growth of the global patient temperature monitoring market over the forecast period. For instance, in April 2022, Exergen Corporation, a manufacturer of infrared scanners, thermometer, and sensors calls on U.S. Food and Drug Administration (FDA) to recall and prevent future sales of non-contact infrared thermometers, whose inaccuracy is danger to the public health.

Moreover, a new U.S. Food and Drug Administration (FDA) published study demonstrates the failure of non-contact infrared thermometers (NCITs) to reliably detect fevers when used on adults in accordance with the NCITs instructions, and fail to be within the accuracy specifications as advertised in manufacturers literature, instruction for use, and other labeling is expected to hamper the market growth.

Moreover, in August 2018, Medtronic, a medical device company received notification from the original equipment manufacturer Degania Silicon that they are recalling specific production lots of Mon-a-Therm Foley catheters with temperature sensors due to defective temperature sensors that show lower body temperature measurements than the actual temperature of a patient.